Breaking News

Guardant Health launches test to spot colon cancer; how cancer-killing cell therapies work

    

 

Cancer Briefing

STAT+: Early cancer-detection market heats up as Guardant Health launches colon cancer test

By Jonathan Wosen

The launch of Shield marks a move into spotting cancer before people even have symptoms, when treatment often has the best chance to work.

Read More

Listen: How cancer-killing cell therapies work, biotech's endless downturn, & an FDA conundrum

By Damian Garde and Meg Tirrell and Adam Feuerstein

Immunologist Katy Rezvani of MD Anderson Cancer Center joins us to explain the massive potential of a new approach to treating wily tumors.

Read More

STAT+: U.S. Trade Rep report sparks concern that a new clash may occur over clinical trial transparency

By Ed Silverman

Adobe

The U.S. Trade Representative claims a European Medicines Agency policy may disclose industry trade secrets contained in clinical study reports.

Read More

Tuesday, May 3, 2022

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2022, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us | View In Browser

No comments